Accès ouvert déclaré2025article

Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial

Moses R. Kamya, Joaniter I. Nankabirwa, Chris Ebong, Victor Asua, Moses Ν. Kiggundu, Stephen Orena, Martin Okitwi, Stephen Tukwasibwe, Bosco Agaba, Daniel Kyabayinze, Jimmy Opigo, Damian Rutazana, Benjamin Binagwa, Edward Mugwanya, Shakira Babirye, Gloria Sebikaari, Patrick Condo, Grace D. Appiah, Samuel L. Nsobya, Melissa D. Conrad, Philip J. Rosenthal, Leah F. Moriarty, Adoke Yeka

16Citations signalées
10Institutions associées
2Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.

Institutions

Infectious Diseases Research CollaborationMakerere UniversityMbarara University of Science and TechnologyMinistry of HealthMalaria ConsortiumU.S. President's Malaria InitiativeUnited States Agency for International DevelopmentCenters for Disease Control and PreventionUniversity of California, San FranciscoCenters for Disease Control and Prevention

Sujets associés

Malaria Research and ControlPharmaceutical Quality and CounterfeitingHistorical Medical Research and Treatments
Lire en accès ouvert Voir la notice officielleDOI

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.